CpG Oligonucleotides Are Potent Adjuvants for the Activation of Autoreactive Encephalitogenic T Cells In Vivo
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The mechanism of action of microbial adjuvants in promoting the differentiation of autoimmune effector cells remains to be elucidated. We demonstrate that CpG-containing oligodeoxynucleotides (ODN) can completely substitute for heat-killed mycobacteria in the priming of encephalitogenic myelin-reactive T cells in vivo. The adjuvanticity of the CpG ODN was secondary to their direct ability to induce IL-12 or to act synergistically with endogenous IL-12 to promote Th1 differentiation and encephalitogenicity. T cells primed in the absence of CpG with Ag and IFA alone appeared to be in a transitional state and had not undergone differentiation along a conventional Th pathway. Unlike Th2 cells, they expressed low levels of the IL-12Rβ2 subunit and retained the ability to differentiate into encephalitogenic effectors when reactivated in vitro under Th1-polarizing conditions. These results support the use of CpG ODN as adjuvants but also suggest that they could potentially trigger autoimmune disease in a susceptible individual.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men
Jouanguy, E., Döffinger, R., Dupuis, S., Pallier, A., Altare, F., & Casanova, J.-L. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80055-7 · Cited by 331 · cited 1×
“Normally, this type of cross-talk is beneficial to the host; Th1 responses are most effective in eradicating mycobacterial infections ( 32 ).”
Background
Cited by
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V., & Segal, B. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080159 · Cited by 579
Self-citationActive induction of experimental allergic encephalomyelitis
Stromnes, I. M., & Goverman, J. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.285 · Cited by 573
The roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513
Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential
Hanke, M. L., & Kielian, T. (2011) · Clinical Science · doi:10.1042/cs20110164 · Cited by 492
TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
Lampropoulou, V., Hoehlig, K., Roch, T., Neves, P., Gómez, E. C., Sweenie, C. H., Hao, Y., Freitas, A. A., Steinhoff, U., Anderton, S. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4763 · Cited by 436
“As a consequence of their capacity to stimulate both innate and adaptive immunity, TLR agonists can be used to break immunological tolerance and induce autoimmune diseases such as arthritis (23), experimental autoimmune encephalomyelitis (EAE) (24), and diabetes (25).”
BackgroundInnate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
Prinz, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26078 · Cited by 380
Cathepsin K-Dependent Toll-Like Receptor 9 Signaling Revealed in Experimental Arthritis
Asagiri, M., Hirai, T., Kunigami, T., Kamano, S., Gober, H.-J., Okamoto, K., Nishikawa, K., Latz, E., Golenbock, D. T., Aoki, K., et al. (2008) · Science · doi:10.1126/science.1150110 · Cited by 364
Toll‐like receptors in central nervous system glial inflammation and homeostasis
Kielian, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20767 · Cited by 361
Toll‐like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Krieg, A. M., & Vollmer, J. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00572.x · Cited by 350
Use of CpG oligodeoxynucleotides as immune adjuvants
Klinman, D. M., Currie, D., Gursel, I., & Verthelyi, D. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00148.x · Cited by 306
Nanoparticles and microparticles as vaccine-delivery systems
Singh, M., Chakrapani, A., & O’Hagan, D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.797 · Cited by 259
mRNA as gene therapeutic: How to control protein expression
Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232
Hopkins, R. J., Daczkowski, N. F., Kaptur, P. E., Muse, D., Sheldon, E., LaForce, C., Sari, S., Rudge, T. L., & Bernton, E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.063 · Cited by 70
Li, Y., Heuser, J. S., Kosanke, S. D., Hemric, M., & Cunningham, M. W. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62948-3 · Cited by 39
“These results were consistent with previous studies that suggested that T cells induced by antigen:IFA may be in a transitional state and retain the ability to differentiate into pathogenic effectors under Th1-polarizing conditions.(56,67,68) Our data also suggested that antigen:IFA-induced tolerance to myocarditis is…”
Metadata
- Authors
- Segal, B. M., Chang, J. T., & Shevach, E. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-06-01
- Volume
- 164
- Issue
- 11
- Pages
- 5683-5688
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1485179699
- Cited by
- 154
- References
- 2
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.